Bayer HealthCare Launches Make Your Mark to Inspire Women and Celebrate Their Achievements
Contest forges a unique partnership among three entities committed to women's empowerment: Bayer HealthCare, Glamour and actress Zosia Mamet
WHIPPANY, N.J. – [September 8, 2014] / PR Newswire / — Bayer HealthCare, maker of Skyla® (levonorgestrel-releasing intrauterine system) 13.5 mg, today announces the Skyla® Make Your Mark contest, designed to inspire and celebrate women who are looking to make their mark on the world. In a joint project with Glamour and actress Zosia Mamet of the HBO hit TV series Girls, the nationwide call for entries into the Skyla® Make Your Mark contest is open to U.S. residents over the age of 18, now through October 1.
Women who enter the Skyla® Make Your Mark contest may be pursuing artistic expression, seeking knowledge through education or research, trailblazing entrepreneurship, performing daring physical feats or undertaking philanthropic endeavors. The contest seeks to not only celebrate the unique and brave things women are doing, but also to inspire others to follow suit. Women are asked to submit a brief essay and photo or video about how they are making their mark to the contest website at www.glamour.com/make-your-mark. Glamour will review all contest entries for content and substance, and all entries will be judged on the basis of appropriateness to contest themes, relatability, and ability to inspire.
Glamour believes that achieving your aspirations can take on many different forms. From its inception, Glamour has celebrated women who make a difference, big and small. Similarly, Bayer is a champion for inspiring and empowering women. Together, Bayer, Glamour and Zosia Mamet share a commitment to speaking to women honestly, directly and always with optimism.
"We all have stories, and they all deserve to be heard," said spokeswoman Zosia Mamet. "Glamour, Bayer and I want to give women a platform to share their stories and to show the world how they're making their mark. We all make our marks in different ways; what's yours?"
The Skyla® Make Your Mark contest winner will receive a $5,000 grant, a trip to NYC to attend Glamour's Women of the Year Gala, and may be featured on a promotional page in an upcoming issue of Glamour. Women can enter the contest at www.glamour.com/make-your-mark by submitting their story and a photo or video of how they are making their mark. The contest will run through October 1. Visit www.glamour.com/make-your-mark for more information and to read the full contest rules.
Skyla is a hormone-releasing IUD (intrauterine device) that prevents pregnancy for up to 3 years.
Important Safety Information
If you have a pelvic infection, get infections easily, or have certain cancers, don't use Skyla. Less than 1% of users get a serious pelvic infection called PID.
If you have persistent pelvic or stomach pain or if Skyla comes out, tell your doctor. If Skyla comes out, use back-up birth control. Skyla may attach to or go through the uterus and cause other problems.
Pregnancy while using Skyla is uncommon but can be life threatening and may result in loss of pregnancy or fertility. Ovarian cysts may occur but usually disappear.
Bleeding and spotting may increase in the first 3 to 6 months and remain irregular. Periods over time usually become shorter, lighter, or may stop.
Skyla does not protect against HIV or STDs.
Only you and your healthcare provider can decide if Skyla is right for you. Skyla is available by prescription only.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional information about Skyla, please see full prescribing information at www.skyla-us.com.
Skyla® Make Your Mark Contest Rules
NO PURCHASE NECESSARY. To enter and for full rules, go to www.glamour.com/make-your-mark. Starts 12:01 AM ET 8/12/14 and ends 11:59 PM ET 10/1/14. Open to legal residents of the 50 United States/D.C. 18 or older, except employees of Sponsors, their immediate families and those living in the same household. Void outside the 50 United States/D.C. and where prohibited. A.R.V. of prize: up to $8,500. Sponsors: Condé Nast and Bayer. Winner must be prepared to travel to New York City the week of October 13, 2014.
About Zosia Mamet
In film and television, Zosia Mamet is quickly establishing herself as one of the industry's most exciting new talents. Since the spring of 2012, Mamet has starred in "Girls," the Emmy Award and Golden Globe Award winning HBO series critically acclaimed for taking a comic look at the assorted humiliations and rare triumphs of a group of girls in their early 20s. In the role of 'Shoshanna,' she aspires to the "Sex and the City" lifestyle.
In addition to her work in film and television, Mamet is a devoted writer. "To share my heart, and soul and the thoughts in my head, to tell a story; is a terrifying and thrilling experience that I wouldn't trade for the world," says Mamet. "That's why I write."
Mamet will next star in the indie thriller "Shiva & May." Other upcoming projects include roles in "Outliving Emily," "Olympia Dukakis," and the USA drama series, "Dominion" with John Malkovich. Mamet is a paid spokesperson for the Skyla® Make Your Mark contest.
About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.
Intended for U.S. media only
Tara DiFlumeri, Communications, Bayer HealthCare
Telephone: (862) 404-4081
E-Mail: [email protected]
This release may contain forward looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Bayer, the Bayer Cross and Skyla are registered trademarks of Bayer.